Award Information
Awardee
Award #
2008-DN-BX-K299
Funding Category
Competitive
Location
Congressional District
Status
Closed
Funding First Awarded
2008
Total funding (to date)
$200,621
Original Solicitation
Description of original award (Fiscal Year 2008, $200,621)
DNA Polymerase Technology, Inc. has engineered novel DNA polymerases that are highly resistant to PCR inhibition. In the current project, these newly-engineered DNA polymerase will be used to improve current protocols for typing human STR loci, mitochondrial DNA, and the Y chromosome. They will also formulate a blend of mutants and two novel thermophilic polymerases for improving the enzyme performance with damaged DNA.
ca/ncf
Date Created: September 15, 2008
Similar Awards
- Mechanics of Retinal Hemmorhage in Abusive Head Trauma
- Developing a Strategy to Evaluate Urban Violence Prevention and Intervention Ecosystems: A Case Study of Boston
- Nanoparticle-Decorated Micropillars As Integrated Raman Spectroscopy and Mass Spectrometry Substrates for Quantitative and High-Throughput Toxicology Drug Analysis